GEARING UP FOR WWJ 950'S THAW RADIOTHON: DONATE ONLINE HERE  

Retinal Degeneration

RetroSense Therapeutics Completes pre-IND Meeting for RST-001RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research division of the FDA that took place on May 22 regarding RetroSense’s lead product candidate, RST-001 for vision restoration in retinal degenerative conditions.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen